RankingsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Capital expenditures

KAKEN PHARMACEUTIAL CO., LTD.【JP:4521】

Market cap
¥188.4B
P/E ratio
67.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-4,138+122.35%
Mar 31, 2024-1,861-6.34%
Mar 31, 2023-1,987-33.46%
Mar 31, 2022-2,986+51.34%
Mar 31, 2021-1,973-8.62%
Mar 31, 2020-2,159+13.16%
Mar 31, 2019-1,908+12.97%
Mar 31, 2018-1,689-22.02%
Mar 31, 2017-2,166-30.67%
Mar 31, 2016-3,124+59.88%
Mar 31, 2015-1,954

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)